Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Reports 15-Percent Spike in Q3 Bio-Analytical Revenues

NEW YORK (GenomeWeb News) – Agilent Technologies yesterday reported a 15-percent increase in third-quarter revenues for its Bio-Analytical Measurement business as deliveries of new products accelerated, the company said.
For the third fiscal quarter ended July 31, Agilent reported $391 million in revenues for the Bio-Analytical business, a 15-percent spike from $341 million in the same quarter last year. The company said it recorded $387 million in orders in Q3, an 11-percent increase from $348 million one year ago.
Agilent said that Life Sciences orders increased 13 percent, while Chemical Analysis orders jumped 10 percent over the year-ago period. The company said that “robust” growth in Asia and Europe was balanced by single-digit growth in the Americas due to ongoing weakness from traditional large pharmaceutical companies.
Agilent Technologies’ total revenues for Q3 increased 17 percent to $1.45 billion from $1.24 billion in the same quarter last year. The company’s net income rose 118 percent to $227 million from $104 million a year ago.
Agilent spent $186 million on R&D in Q3 2006, compared with $183 million in the third quarter of 2005.

As of July 31, Agilent said it had $2.3 billion in cash and cash equivalents on hand.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.